Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults — Canadian Journal of Psychiatry (2024)• Drug: selegilineDOIPMID
- Monoamine oxidase inhibitors: Seriously underused in the treatment of major depression — Acta Psychiatrica Scandinavica (2024)• Drug: selegilineDOI
- APA Clinical Practice Guideline for the Treatment of Depression — American Psychiatric Association (2023)• Drug: selegilineOpen access
- Consensus recommendations for MAOI safety and dietary management — Journal of Clinical Psychopharmacology (2022)• Drug: selegilineDOI